AriBio wraps up global phase 3 trial of AR1001, sets stage for topline results Korea Biomedical Review 02:02 Tue, 28 Jul
AriBio to present AR1001 phase 3 results at CTAD 2026 in Boston Korea Biomedical Review 01:09 Wed, 22 Jul